Skip to main content
NIH funding notice PA-13-224

Improvement of Animal Models and Development of Technologies for Stem Cell-Based Regenerative Medicine (STTR)(R41/R42)

Closed on April 5, 2016.

Posted
May 8, 2013
Close date
April 5, 2016
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $299,955 in first-year total cost, median $149,978.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 IMST-J (15)]2

Most frequent institutions

  1. 490 BIOTECH, INC.1
  2. GENESEARCH, INC.1
Competing awards under PA-13-224 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2015Mouse Stem Cell Research Using the Dracula Pipette1R42OD018404-01A1TAYLOR, PAUL JONGENESEARCH, INC., MT$149,995ZRG1
2015Expressing humanized bacterial luciferase in stem cells: Moving beyond firefly luciferase to expand the informational capacity of animal models for regenerative medicine1R41GM116622-01MORRISON, DAN490 BIOTECH, INC., TN$149,960ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.